Gender Differences in the Control of Energy Homeostasis

Experimental Biology and Medicine

Volumn 228, Issue 10, 2003, Pages 1175-1180

  Woods, Stephen C ^a   Gotoh, Koro ^a   Clegg, Deborah J ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Gender difference; Leptin; Obesity; Subcutaneous fat; Visceral fat

Indexed keywords

LEPTIN;

BODY FAT; CONFERENCE PAPER; ENERGY BALANCE; HORMONAL REGULATION; HUMAN; HYPOTHALAMUS; LIPID STORAGE; NONHUMAN; OBESITY; SEX DIFFERENCE; SUBCUTANEOUS FAT; TISSUE DISTRIBUTION;

EID: 0242694039     PISSN: 15353702     EISSN: None     Source Type: Journal    
DOI: 10.1177/153537020322801012     Document Type: Conference Paper

References (85)

1. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 288:1723-1727, 2002.
2. Popkin BM, Paeratakul S, Zhai F, Ge K. Dietary and environmental correlates of obesity in a population study in China. Obes Res 3(Suppl):135S-143S, 1995.
3. Popkin BM, Doak C. The obesity epidemic is a worldwide phenomenon. Nutr Rev 56:106-114, 1998.
4. Ogden CL, Flegal KM, Carroll MD, Johnson CL. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 288:1728-1732, 2002.
5. Health and Human Services. The Surgeon General's Call to Action To Prevent and Decrease Overweight and Obesity. In: U.S. Public Health Service, Office of the Surgeon General, Washington, D.C., 2001.
6. McNutt SW, Hu Y, Schreiber GB, Crawford PB, Obarzanek E, Mellin L. A longitudinal study of the dietary practices of black and white girls 9 and 10 years old at enrollment: the NBLBI Growth and Health Study. J Adolesc Health 20:27-37, 1997.
7. Cummings DE, Schwartz MW. Genetics and pathophysiology of human obesity. Ann Rev Med 54:453-471, 2003.
8. Eckel RH, Barouch WW, Ershow AG. Report of the National Heart Lung and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on the Pathophysiology of Obesity-Associated Cardiovascular Disease. Circulation 105:2923-2928, 2002.
9. World Health Organization Obesity. Preventing and managing the global epidemic. In: World Health Organization, Geneva, 1998
10. Keesey RE, Hirvonen MD. Body weight set-points: determination and adjustment. J Nutr 127:1875S-1883S, 1997.
11. Schwartz MW, Woods SC, Porte DJ, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature 404:661-671, 2000.
12. Woods SC, Seeley RJ. Adiposity signals and the control of energy homeostasis. Nutrition 16:894-902, 2000.
13. Woods SC, Seeley RJ, Porte DJ, Schwartz MW. Signals that regulate food intake and energy homeostasis. Science 280:1378-1383, 1998.
14. Pinel JPJ, Assanand S, Lehman DR. Hunger, eating and ill health. Am Psychol 55:1105-1116, 2000.
15. Woods SC. The eating paradox: How we tolerate food. Psychol Rev 98:488-505, 1991.
16. Woods SC, Strubbe JH. The psychobiology of meals. Psychonomic Bulletin and Review 1:141-155, 1994.
17. Strubbe JH, Woods SC. The timing of meals. Psychol Rev. (in press).
18. Kennedy GC. The role of depot fat in the hypothalamic control of food intake in the rat. Proc R Soc Lond 140:579-592, 1953.
19. Ahima RS, Saper CB, Flier JS, Elmquist JK. Leptin regulation of neuroendocrine systems. Front Neuroendocrinol 21:263-307, 2000.
20. Elmquist JK, Elias CF, Saper CB. From lesions to leptin: Hypothalamic control of food intake and body weight. Neuron 22:221-232, 1999.
21. Seeley R, Schwartz M. Neuroendocrine regulation of food intake. Acta Paediatrica Supplement 88:58-61, 1999.
22. Woods SC, Schwartz MW, Baskin DG, Seeley RJ. Food intake and the regulation of body weight. Annu Rev Psychol 51:255-277, 2000.
23. Banks WA, Kastin AJ, Huang W. Leptin enters the brain by a saturable system independent of insulin. Peptides 17:305-311, 1996.
24. Banks WA, Jaspan JB, Kastin AJ. Effect of diabetes mellitus on the permeability of the blood-brain barrier to insulin. Peptides 18:1577-1584, 1997.
25. Banks WA, DiPalma CR, Farrell CL. Impaired transport of leptin across the blood-brain barrier in obesity. Peptides 20:1341-1345, 1999.
26. Baura G, Foster D, Porte D, Jr Kahn SE, Bergman RN, Cobelli C, Schwartz MW. Saturable transport of insulin from plasma into the central nervous system of dogs in vivo: a mechanism for regulated insulin delivery to the brain. J Clin Invest 92:1824-1830, 1993.
27. Baura GD. Quantitation of central nervous system uptake and its regulation by steroids and obesity. In: Doctoral Dissertation. University of Washington Press 1993.
28. Schwartz MW, Sipols AJ, Kahn SE, Lattemann DP, Taborsky GJ, Jr Bergman RN, Woods SC, Porte D. Kinetics and specificity of insulin uptake from plasma into cerebrospinal fluid. Am J Physiol 259:E378-E383, 1990.
29. Cone RD, Cowley MA, Butler AA, Fan W, Marks DL, Low MJ. The arcuate nucleus as a conduit for diverse signals relevant to energy homeostasis. Int J Obes Relat Metab Disord 25(Suppl 5):S63-S67, 2001.
30. Woods SC, Figlewicz DP, Madden L, Porte JD, Sipols AJ, Seeley RJ. NPY and food intake: Discrepancies in the model. Regul Peptides 75-76:403-408, 1998.
31. McMinn JE, Wilkinson CW, Havel PJ, Woods SC, Schwartz MW. Effect of intracerebroventricular alpha-MSH on food intake, adiposity, c-Fos induction, and neuropeptide expression. Am J Physiol 279:R695-R703, 2000.
32. Seeley R, Yagaloff K, Fisher S, Burn P, Thiele T, van DG, Baskin D, Schwartz M. Melanocortin receptors in leptin effects. Nature 390:349, 1997.
33. Benoit SC, Air EL, Coolen LM, Strauss R, Jackman A, Clegg DJ, Seeley RJ, Woods SC. The catabolic action of insulin in the brain is mediated by melanocortins. J Neurosci 22:9048-9052, 2002.
34. Barsh GS, Farooqi IS, O'Rahilly S. Genetics of body-weight regulation. Nature 404:644-651, 2000.
35. Comuzzie AG, Hixson JE, Almasy L, Mitchell BD, Mahaney MC, Dyer TD, Stern MP, MacCluer JW, Blangero J. A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2. Nat Genet 15:273-276, 1997.
36. Campfield LA, Smith FJ, Gulsez Y, Devos R. Burn P. Mouse OB Protein: Evidence for a peripheral signal linking adiposity and central neural networks. Science 269:546-549, 1995.
37. Sipols AJ, Baskin DG, Schwartz MW. Effect of intracerebroventricular insulin infusion on diabetic hyperphagia and hypothalamic neuropeptide gene expression. Diabetes 44:147-151, 1995.
38. Niswender KD, Schwartz MW. Insulin and leptin revisited: adiposity signals with overlapping physiological and intracellular signaling capabilities. Front Neuroendocrinol 24:1-10, 2003.
39. Porte DJ, Baskin DG, Schwartz MW. Leptin and insulin action in the central nervous system. Nutr Rev 60:S20-S29, 2003.
40. Billington CJ, Briggs JE, Grace M, Levine AS. Effects of intracerebroventricular injection of neuropeptide Y on energy metabolism. Am J Physiol 260:R321-R327, 1991.
41. Clark JT, Kalra PS, Crowley WR, Kalra SP. Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology 115:427-429, 1984.
42. Stanley BG, Leibowitz SF. Neuropeptide Y: stimulation of feeding and drinking by injection into the paraventricular nucleus. Life Sciences 35:2635-2642, 1984.
43. Baskin DG, Breininger JF, Schwartz MW. Leptin receptor mRNA identifies a subpopulation of neuropeptide Y neurons activated by fasting in rat hypothalamus. Diabetes 48:828-833, 1999.
44. Schwartz MW, Marks J, Sipols AJ, Baskin DG, Woods SC, Kahn SE, Porte D Jr. Central insulin administration reduces neuropeptide Y mRNA expression in the arcuate nucleus of food-deprived lean (Fa/Fa) but not obese (fa/fa) Zucker rats. Endocrinology 128:2645-2647, 1991.
45. Cone RD, Lu D, Koppula S, Vage DI, Klungland H, Boston B, Chen W, Orth DN, Pouton C, Kesterson RA. The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation. Recent Prog Horm Res 51:287-320, 1996.
46. Cone RD. The Central Melanocortin System and Energy Homeostasis. Trends Endocrinol Metab 10:211-216, 1999.
47. Cone RD, Ed. The Melanocortin Receptors. New Jersey, Humana Press, 2000.
48. Hagan MM, Rushing PA, Pritchard LM, Schwartz MW, Strack AM, Van der Ploeg HT, Woods SC, Seeley RJ. Long-term orexigenic effects of AgRP-(83-132) involve mechanisms other than melanocortin receptor blockade. Am J Physiol 279:R47-R52, 2000.
49. Hagan MM, Benoit SC, Rushing PA, Pritchard LM, Woods SC, Seeley RJ. Immediate and prolonged patterns of agouti-related peptide-(83-132)-induced c-Fos activation in hypothalamic and extrahypothalamic sites. Endocrinology 142:1050-1056, 2001.
50. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, Sewter CP, Digby JE, Mohammed SN, Hurst JA, Cheetham CH, Earley AR, Barnett AH, Prins JB, O'Rahilly S. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387:903-908, 1997.
51. Casabiell X, Pineiro V, Peino R, Lage M, Camina J, Gallego R, Vallejo LG, Dieguez C, Casanueva FF. Gender differences in both spontaneous and stimulated leptin secretion by human omental adipose tissue in vitro: dexamethasone and estradiol stimulate leptin release in women, but not in men. J Clin Endocrinol Metab 83:2149-2155, 1998.
52. Demerath EW, Towne B, Wisemandle W, Blangero J, Chumlea WC, Siervogel RM. Serum leptin concentration, body composition, and gonadal hormones during puberty. Int J Obes Relat Metab Disord 23:678-685, 1999.
53. Rosenbaum M, Nicolson M, Hirsch J, Heymsfield SB, Gallagher D, Chu F, Leibel RL. Effects of gender, body composition, and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab 81:3424-3427, 1996.
54. Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS. Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1:1311-1314, 1995.
55. Clegg DJ, Riedy CA, Smith KA, Benoit SC, Woods SC. Differential sensitivity to central leptin and insulin in male and female rats. Diabetes 52:682-687, 2003.
56. Ostlund RE Jr, Yang JW, Klein S, Gingerich R. Relation between plasma leptin concentration and body fat, gender, diet, age, and metabolic covariates. J Clin Endocrinol Metab 81:3909-3913, 1996.
57. Kennedy A, Gettys TW, Watson P, Wallace P, Ganaway E, Pan Q, Garvey WT. The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. J Clin Endocrinol Metab 82:1293-1300, 1997.
58. Saad M, Damani S, Gingerich RL, Riad-Gabriel MG, Khan A, Boyadjian R, Jinagouda SD, el-Tawil K, Rude RK, Kamdar V. Sexual dimorphism in plasma leptin concentration. J Clin Endocrinol Metab 82:579-584, 1997.
59. Bjorntorp P. Hormonal control of regional fat distribution. Human Reproduction 12(Suppl 1):21-25, 1997.
60. Bjorntorp P. Obesity. Lancet 350:423-426, 1997.
61. Bjorntorp P. Body fat distribution, insulin reistance, and metabolic diseases. Nutrition 13:795-803, 1997.
62. Dua A, Hennes MI, Hoffman RG, Maas DL, Krakower GR, Sonnenberg GE, Kissebah AH. Leptin: A significant indicator of total body fat but not of visceral fat and insulin insensitivity in African-American women. Diabetes 45:1635-1637, 1996.
63. Havel PJ, Kasim-Karakas S, Dubuc GR, Mueller W, Phinney SD. Gender differences in plasma leptin concentrations. Nat Med 2:949-950, 1996.
64. Havel PJ, KasimKarakas S, Mueller W, Johnson PR, Gingerich RL, Stern JS. Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: Effects of dietary fat content and sustained weight loss. J Clin Endocrinol Metab 81:4406-4413, 1996.
65. Legato MJ. Gender-specific aspects of obesity. Int J Fertil Womens Med 42:184-197, 1997.
66. Kotani K, Tokunaga K, Fujioka S, Kobatake T, Keno Y, Yoshida S, Shimomura I, Tarui S, Matsuzawa Y. Sexual dimorphism of age-related changes in whole-body fat distribution in the obese. Int J Obes Relat Metab Disord 18:207-212, 1994.
67. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21:697-738, 2000.
68. Despres JP. The insulin-resistance-dyslipidemic syndrome of visceral obesity: Effect on patients' risk. Obesity Research 6(Suppl 1):8S-17S, 1998.
69. Lamarche B. Abdominal obesity and its metabolic complications: implications for the risk of ischaemic heart disease. Coron Artery Dis 9:473-481, 1998.
70. Marin P, Andersson B, Ottosson M, Olbe L, Chowdhury B, Kvist H, Holm G, Sjostrom L, Bjorntorp P. The morphology and metabolism of intraabdominal adipose tissue in men. Metabolism 41:1242-1248, 1992.
71. Marin P, Holmang S, Jonsson L, Sjostrom L, Kvist H, Holm G, Lindstedt G, Bjorntorp P. The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int J Obes Relat Metab Disord 16:991-997, 1992.
72. Bolinder J, Ostman J, Arner P. Influence of aging on insulin receptor binding and metabolic effects of insulin on human adipose tissue. Diabetes 32:959-964, 1983.
73. Bolinder J, Engfeldt P, Ostman J, Arner P. Site differences in insulin receptor binding and insulin action in subcutaneous fat of obese females. J Clin Endocrinol Metab 57:455-461, 1983.
74. Carey DG, Jenkins AB, Campbell LV, Freund J, Chisholm DJ. Abdominal fat and insulin resistance in normal and overweight women: Direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes 45:633-638, 1996.
75. O'Shaughnessy IM, Myers TJ, Stepniakowski K, Nazzaro P, Kelly TM, Hoffmann RG, Egan BM, Kissebah AH. Glucose metabolism in abdominally obese hypertensive and normotensive subjects. Hypertension 26:186-192, 1995.
76. Colombel A, Charbonnel B. Weight gain and cardiovascular risk factors in the post-menopausal women. Hum Reprod 12:134-145, 1997.
77. Bjorkelund C, Lissner L, Andersson S, Lapidus L, Bengtsson C. Reproductive history in relation to relative weight and fat distribution. Int J Obes Relat Metab Disord 20:213-219, 1996.
78. Gambacciani M, Ciaponi M, Cappagli B, Piaggesi L, De Simone L, Orlandi R, Genazzani AR. Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women. J Clin Endocrinol Metab 82:414-417, 1997.
79. Haarbo J, Hansen BF, Christiansen C. Hormone replacement therapy prevents coronary artery disease in ovariectomized cholesterol-fed rabbits. Apmis 99:721-727, 1991.
80. Haarbo J, Marslew U, Gotfredsen A, Christiansen C. Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism 40:1323-1326, 1991.
81. Bouchard C, Despres JP, Mauriege P. Genetic and nongenetic determinants of regional fat distribution. Endocr Rev 14:72-93, 1993.
82. Tchernof A, Calles-Escandon J, Sites CK, Poehlman ET. Menopause, central body fatness, and insulin resistance: Effects of hormone-replacement therapy. Coron Artery Dis 9:503-511, 1998.
83. Hill JO, Wyatt HR, Reed GW, Peters JC. Obesity and the environment: where do we go from here? Science 299:853-855, 2003.
84. Gotoh K, Seeley RJ, D'Alessio DA, Tso P, Woods SC. High-fat diet prevents the anorectic effect of central insulin. In: Schwartz, MW, Collins S, Barsh GS, Eds. Keystone Symposium: Obesity, New Insights into Pathogenesis and Treatment. p136, 2003.
85. Woods SC, Seeley RJ, Rushing PA, D'Alessio DA, Tso P. A controlled high-fat diet induces an obese syndrome in rats. J Nutr 133:1081-1087, 2003.